Market by Cellulite Type, Procedure Type, End-user, and Country Outlook | Forecast 2023-2030
Based on Triton Market Research’s report, the cellulite treatment market in the Middle East and Africa is projected to display a CAGR of 8.67% during the forecast years 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries measured in the region comprise:
•
United Arab Emirates
•
Saudi Arabia
•
Turkey
•
South Africa
•
Rest of Middle East & Africa
The growing aging population, changing
lifestyles, and rise in disposable income are among the major factors driving
the studied market across the region. Other than this, the growing medical
tourism industry and investments in healthcare services have fueled the demand
for various procedures, including cosmetic treatments. Thus, the rise in
medical tourism and investments in healthcare are anticipated to fuel the
cellulite treatment market’s growth during the forecast period.
Saudi
Arabia captures the highest share of the cellulite treatment market. As per estimates, obesity levels have surged
significantly over the recent years. Moreover, the number of aged people above
60 years is anticipated to surge five-fold by 2050. This high prevalence of the
aged and obese population is projected to elevate the demand for cosmetic
treatments like cellulite reduction. The growing beauty consciousness and
investments in the personal care industry are also set to increase demand for
these treatments, thereby driving the studied market’s growth.
Similarly, in South Africa, the growing
investments in the personal care industry and disposable income have influenced
the demand for aesthetic procedures, such as cellulite reduction. The rise in
the elderly population is another factor accelerating the demand for such treatments.
This further widens the scope of the cellulite treatment market across the
nation.
Hospitals have an integrated facility of
non-invasive and minimally invasive devices to provide advanced treatments.
This rapid adoption has increased the number of cellulite treatments conducted
in hospital settings. Healthcare tourism has also prompted the establishment of
numerous hospitals. The market’s growth
is determined based on end-user, cellulite type, and procedure type. The
end-user section includes hospitals, clinics and beauty centers, and other
end-users.
The
well-known companies in the market comprise Galderma SA, Endo International
Plc, Zimmer MedizinSysteme GmbH, Sientra Inc, and Candela Medical Corporation.
Sientra Inc is a medical aesthetics company
offering treatments and technologies for various surgeries, including breast
augmentation, cellulite reduction, scar removal, and breast reconstruction. Its
product line includes Viality, a device used for fat transfer. The company
serves clients across multiple countries, including the US and United Arab
Emirates.
Key deliverables of the report:
● Market CAGR during the forecasting years 2023-2030
● Detailed data highlighting key insights, industry components, and market strategies
● Comprehensive information and estimation of the cellulite treatment market revenue growth in the Middle East and Africa and its influence on the parent market
● In-depth study of forthcoming trends in consumer behavioral patterns
● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces
●
A wide-ranging study of factors that will challenge the Middle
East and Africa cellulite treatment market’s growth during the upcoming years
Want to get specific insights? Our team of analysts
can customize this report based on your preferences. Connect with us here.
Market By Category, Applicatio ..
VIEW REPORT
Market by RTD Type | Forecast ..
VIEW REPORT
Market by Product Type | Forec ..
VIEW REPORT
Market by Product, Application ..
VIEW REPORT
Market By Product Type, Specie ..
VIEW REPORT
Market by Ingredient Type, Age ..
VIEW REPORT
Market By Demographics, Produc ..
VIEW REPORT
Market by Type, Sales Channel, ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1.PARENT
MARKET ANALYSIS
2.2.IMPACT
ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1.COVID-19
IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2.UKRAINE-RUSSIA
WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3.PORTER’S
FIVE FORCES ANALYSIS
2.3.1.THREAT
OF NEW ENTRANTS
2.3.2.THREAT
OF SUBSTITUTES
2.3.3.BARGAINING
POWER OF BUYERS
2.3.4.BARGAINING
POWER OF SUPPLIERS
2.3.5.THREAT
OF COMPETITIVE RIVALRY
2.4.MARKET
MATURITY ANALYSIS
2.5.INDUSTRY
COMPONENTS
2.5.1.RESEARCH
AND DEVELOPMENT
2.5.2.MANUFACTURING
OF PRODUCT
2.5.3.DISTRIBUTION
2.5.4.POST-SALES
MONITORING
2.6.REGULATORY
FRAMEWORK
2.7.KEY
BUYING IMPACT ANALYSIS
2.7.1.PRICE
2.7.2.BRAND
NAME
2.7.3.USABILITY
2.8.KEY
MARKET STRATEGIES
2.8.1.COLLABORATIONS
2.8.2.PRODUCT
LAUNCHES
2.8.3.MERGERS
& ACQUISITIONS
2.8.4.BUSINESS
DIVESTITURES & EXPANSIONS
2.9.MARKET
DRIVERS
2.9.1.GROWING
PREVALENCE OF OBESITY
2.9.2.RAPIDLY
GROWING MEDICAL TOURISM SECTOR
2.9.3.RISING
DEMAND FOR AESTHETIC PROCEDURES
2.10.MARKET
CHALLENGES
2.10.1.LACK
OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2.HIGH
PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3.RISKS
ASSOCIATED POST-TREATMENT
2.11.MARKET
OPPORTUNITIES
2.11.1.RISING
BEAUTY CONSCIOUSNESS
2.11.2.INCREASING
TREND OF ANTI-CELLULITE MASSAGE
2.11.3.GROWING
DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4.RISING
POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5.ADVANCEMENTS
IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12.ANALYST
PERSPECTIVE
3. MIDDLE
EAST AND AFRICA CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1.SOFT
CELLULITE
3.2.HARD
CELLULITE
3.3.EDEMATOUS
CELLULITE
4. MIDDLE
EAST AND AFRICA CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1.NON-INVASIVE
4.2.MINIMALLY
INVASIVE
4.3.TOPICAL
5. MIDDLE
EAST AND AFRICA CELLULITE TREATMENT MARKET – BY END-USER
5.1.HOSPITALS
5.2.CLINICS
AND BEAUTY CENTERS
5.3.OTHER
END-USERS
6. MIDDLE
EAST AND AFRICA CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK
6.1.COUNTRY
ANALYSIS
6.1.1.UNITED
ARAB EMIRATES
6.1.1.1.UNITED
ARAB EMIRATES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.2.TURKEY
6.1.2.1.TURKEY
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.3.SAUDI
ARABIA
6.1.3.1.SAUDI
ARABIA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.4.SOUTH
AFRICA
6.1.4.1.SOUTH
AFRICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.5.REST
OF MIDDLE EAST & AFRICA
6.1.5.1.REST
OF MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1.JOHNSON
& JOHNSON
7.1.1.OVERVIEW
7.1.2.PRODUCT
PORTFOLIO
7.1.3.KEY
STRENGTHS
7.1.4.KEY
CHALLENGES
7.2.ABBVIE
INC
7.2.1.OVERVIEW
7.2.2.PRODUCT
PORTFOLIO
7.2.3.KEY
STRENGTHS
7.2.4.KEY
CHALLENGES
7.3.BAUSCH
HEALTH COMPANIES INC
7.3.1.OVERVIEW
7.3.2.PRODUCT
PORTFOLIO
7.3.3.KEY
STRENGTHS
7.3.4.KEY
CHALLENGES
7.4.CUTERA
INC
7.4.1.OVERVIEW
7.4.2.PRODUCT
PORTFOLIO
7.4.3.KEY
STRENGTHS
7.4.4.KEY
CHALLENGES
7.5.INCELER
MEDIKAL
7.5.1.OVERVIEW
7.5.2.PRODUCT
PORTFOLIO
7.5.3.KEY
STRENGTHS
7.5.4.KEY
CHALLENGES
7.6.ZIMMER
MEDIZINSYSTEME GMBH
7.6.1.OVERVIEW
7.6.2.PRODUCT
PORTFOLIO
7.6.3.KEY
STRENGTHS
7.6.4.KEY
CHALLENGES
7.7.GALDERMA
SA
7.7.1.OVERVIEW
7.7.2.PRODUCT
PORTFOLIO
7.7.3.KEY
STRENGTHS
7.7.4.KEY
CHALLENGES
7.8.SIENTRA
INC
7.8.1.OVERVIEW
7.8.2.PRODUCT
PORTFOLIO
7.8.3.KEY
STRENGTHS
7.8.4.KEY
CHALLENGES
7.9.ENDO
INTERNATIONAL PLC
7.9.1.OVERVIEW
7.9.2.PRODUCT
PORTFOLIO
7.9.3.KEY
STRENGTHS
7.9.4.KEY
CHALLENGES
7.10.CANDELA
MEDICAL CORPORATION
7.10.1.OVERVIEW
7.10.2.PRODUCT
PORTFOLIO
7.10.3.KEY
STRENGTHS
7.10.4.KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1.RESEARCH
SCOPE & DELIVERABLES
8.1.1.OBJECTIVES
OF STUDY
8.1.2.SCOPE
OF STUDY
8.2.SOURCES
OF DATA
8.2.1.PRIMARY
DATA SOURCES
8.2.2.SECONDARY
DATA SOURCES
8.3.RESEARCH
METHODOLOGY
8.3.1.EVALUATION
OF THE PROPOSED MARKET
8.3.2.IDENTIFICATION
OF DATA SOURCES
8.3.3.ASSESSMENT
OF MARKET DETERMINANTS
8.3.4.DATA
COLLECTION
8.3.5.DATA
VALIDATION & ANALYSIS
TABLE 1: MIDDLE EAST AND
AFRICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY
FRAMEWORK
TABLE 3: LIST OF
COLLABORATIONS
TABLE 4: LIST OF
PRODUCT LAUNCHES
TABLE 5: LIST OF
MERGERS & ACQUISITIONS
TABLE 6: LIST OF
BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $
MILLION)
TABLE 8: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $
MILLION)
TABLE 9: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $
MILLION)
FIGURE 1: MARKET
MATURITY ANALYSIS
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: KEY BUYING
IMPACT ANALYSIS
FIGURE 4: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN
%)
FIGURE 5: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $
MILLION)
FIGURE 6: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $
MILLION)
FIGURE 7: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN
%)
FIGURE 8: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $
MILLION)
FIGURE 9: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $
MILLION)
FIGURE 10: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030
(IN $ MILLION)
FIGURE 14: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $
MILLION)
FIGURE 15: MIDDLE EAST
AND AFRICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN
%)
FIGURE 16: UNITED ARAB
EMIRATES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: TURKEY
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: SAUDI ARABIA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: SOUTH AFRICA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: REST OF
MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)